171 related articles for article (PubMed ID: 12191724)
1. Comparison of UV- and second derivative-spectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulation.
Tatar S; Sağlík S
J Pharm Biomed Anal; 2002 Sep; 30(2):371-5. PubMed ID: 12191724
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of valsartan and hydrochlorothiazide in tablets by first-derivative ultraviolet spectrophotometry and LC.
Satana E; Altinay S; Göğer NG; Ozkan SA; Sentürk Z
J Pharm Biomed Anal; 2001 Jul; 25(5-6):1009-13. PubMed ID: 11377086
[TBL] [Abstract][Full Text] [Related]
3. High-performance liquid chromatographic and first derivative of the ratio spectrophotometric determination of amlodipine and valsartan in their binary mixtures.
Kul D; Dogan-Topal B; Kutucu T; Uslu B; Ozkan SA
J AOAC Int; 2010; 93(3):882-90. PubMed ID: 20629391
[TBL] [Abstract][Full Text] [Related]
4. Concurrent estimation of amlodipine besylate, hydrochlorothiazide and valsartan by RP-HPLC, HPTLC and UV-spectrophotometry.
Sharma M; Kothari C; Sherikar O; Mehta P
J Chromatogr Sci; 2014 Jan; 52(1):27-35. PubMed ID: 23293040
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous spectrophotometric determination of valsartan and hydrochlorothiazide by H-point standard addition method and partial least squares regression.
Lakshmi KS; Lakshmi S
Acta Pharm; 2011 Mar; 61(1):37-50. PubMed ID: 21406342
[TBL] [Abstract][Full Text] [Related]
6. Comparative study between derivative spectrophotometry and multivariate calibration as analytical tools applied for the simultaneous quantitation of Amlodipine, Valsartan and Hydrochlorothiazide.
Darwish HW; Hassan SA; Salem MY; El-Zeany BA
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Sep; 113():215-23. PubMed ID: 23727675
[TBL] [Abstract][Full Text] [Related]
7. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
Krishnaiah Ch; Reddy AR; Kumar R; Mukkanti K
J Pharm Biomed Anal; 2010 Nov; 53(3):483-9. PubMed ID: 20646890
[TBL] [Abstract][Full Text] [Related]
8. Improved analytical validation and pharmacokinetics of valsartan using HPLC with UV detection.
Piao ZZ; Lee ES; Tran HT; Lee BJ
Arch Pharm Res; 2008 Aug; 31(8):1055-9. PubMed ID: 18787797
[TBL] [Abstract][Full Text] [Related]
9. A comparative study on various spectrometries with thin layer chromatography for simultaneous analysis of drotaverine and nifuroxazide in capsules.
Ayad MM; Youssef NF; Abdellatif HE; Soliman SM
Chem Pharm Bull (Tokyo); 2006 Jun; 54(6):807-13. PubMed ID: 16755048
[TBL] [Abstract][Full Text] [Related]
10. Comparison of second derivative-spectrophotometric and reversed-phase HPLC methods for the determination of prednisolone in pharmaceutical formulations.
Singh DK; Verma R
Anal Sci; 2007 Oct; 23(10):1241-3. PubMed ID: 17928675
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of chiral high-performance liquid chromatographic methods for the quantitation of valsartan and of the tosylate of valinebenzyl ester.
Francotte E; Davatz A; Richert P
J Chromatogr B Biomed Appl; 1996 Nov; 686(1):77-83. PubMed ID: 8953194
[TBL] [Abstract][Full Text] [Related]
12. Determination of nebivolol and valsartan in a fixed-dose combination by liquid chromatography.
Doshi AS; Bhagwan SS; Mehta TN; Gupta VK; Subaaiah G
J AOAC Int; 2008; 91(2):292-8. PubMed ID: 18476340
[TBL] [Abstract][Full Text] [Related]
13. Quantitative determination of piroxicam in a new formulation (piroxicam-beta-cyclodextrin) by derivative UV spectrophotometric method and HPLC.
Basan H; Göğer NG; Ertaş N; Orbey MT
J Pharm Biomed Anal; 2001 Sep; 26(2):171-8. PubMed ID: 11470194
[TBL] [Abstract][Full Text] [Related]
14. Electrochemical behavior of valsartan and its determination in capsules.
Yan J; Wang W; Chen L; Chen S
Colloids Surf B Biointerfaces; 2008 Dec; 67(2):205-9. PubMed ID: 18823761
[TBL] [Abstract][Full Text] [Related]
15. Spectrophotometric methods for the determination of letrozole in bulk and pharmaceutical dosage forms.
Acharjya SK; Mallick P; Panda P; Kumar KR; Annapurna MM
J Adv Pharm Technol Res; 2010 Jul; 1(3):348-53. PubMed ID: 22247870
[TBL] [Abstract][Full Text] [Related]
16. Ionic liquids dispersive liquid-liquid microextraction and high-performance liquid chromatographic determination of irbesartan and valsartan in human urine.
Li Z; Chen F; Wang X; Wang C
Biomed Chromatogr; 2013 Feb; 27(2):254-8. PubMed ID: 22733604
[TBL] [Abstract][Full Text] [Related]
17. Rapid and simple methods for quantitative analysis of some antidepressant in pharmaceutical formulations by using first derivative spectrophotometry and HPLC.
Erk N
Farmaco; 2003 Dec; 58(12):1209-16. PubMed ID: 14630230
[TBL] [Abstract][Full Text] [Related]
18. Two derivative spectrophotometric determinations of indapamide in pharmaceutical dosage forms.
Süslü I; Altínöz S
J Pharm Biomed Anal; 2002 Sep; 30(2):357-64. PubMed ID: 12191722
[TBL] [Abstract][Full Text] [Related]
19. Optimization via experimental design of an SPE-HPLC-UV-fluorescence method for the determination of valsartan and its metabolite in human plasma samples.
Iriarte G; Ferreirós N; Ibarrondo I; Alonso RM; Maguregi MI; Gonzalez L; Jiménez RM
J Sep Sci; 2006 Oct; 29(15):2265-83. PubMed ID: 17120810
[TBL] [Abstract][Full Text] [Related]
20. Comparison of UV spectrophotometric method and high performance liquid chromatography for the analysis of flunarizine and its application for the dissolution test.
Busaranon K; Suntornsuk W; Suntornsuk L
J Pharm Biomed Anal; 2006 Apr; 41(1):158-64. PubMed ID: 16352415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
